Skip to content

A clinical trial to find effect of oral steroids in patients of non arteritic ischemic optic neuropathy

To evaluate the role of oral steroids in NON arteritic anterior ischemic optic neuropathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/02/006672
Enrollment
38
Registered
2016-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients presenting with acute NAION will be included

Interventions

Intervention1: Oral steroids: T. Prednisolone 80 mg for two weeks2 weeks, and then tapered down to 70 mg for 5 days, 60 mg for 5 days, and then cutting down by 5 mg every 5 days Control Intervention1:

Sponsors

Rajendra prasad centre for ophthalmic sciences all india institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting within 1 month of symptoms Willing to consent

Exclusion criteria

Exclusion criteria: Diabetics Unwilling to participate less than 50 years old History of any treatment taken for NAION

Design outcomes

Primary

MeasureTime frame
To compare the improvement in visual acuityTimepoint: 1 week, 1 month, three months, six months

Secondary

MeasureTime frame
To compare effects of oral steroids on nerve fibre layer thickness,ganglion cell layer thickness on OCT.Timepoint: 1 week, 1 month, 3 months, 6 months

Countries

India

Contacts

Public ContactDr Rohit Saxena

Rajendra Prasad centre for ophthalmic science

rohitsaxena80@yahoo.com9868155230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026